[Oral long-term administration of probiotic B. cereus--an alternative for the the prevention of enterotoxemia?].
Aetiology and epizootiology of enterotoxaemia, especially the connection between development of the disease and the management of feeding are described and newer knowledge about the physiopathology of the disease is presented. A comparative description of prophylactic schemes which include immuno- and chemoprophylaxis follows. The principles of the application and the effect of probiotic organisms as a new approach to prevent the disease are explained. The probiotic effect of apathogenic non-haemolysing and non-toxic B. cereus strains which have proven to be able to suppress enteropathies and also enterotoxaemia is described.